Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The firm has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.
Mr. Waqaas Al-Siddiq is the Chairman of the Board of Biotricity Inc, joining the firm since 2016.
What is the price performance of BTCY stock?
The current price of BTCY is $0.1207, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Biotricity Inc?
Biotricity Inc belongs to Health Care industry and the sector is Health Care
What is Biotricity Inc market cap?
Biotricity Inc's current market cap is $3.4M
Is Biotricity Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Biotricity Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell